S23 - Genetic Muscle Disorders
Event Time: | Monday May 6, 2019 3:30 pm to 5:30 pm |
Topic(s): | Neuromuscular and Clinical Neurophysiology (EMG) |
Director(s): | |
Description: | |
Completion Message: | |
CME Credits: | 2 |
Core Competencies: |
Start/End Time | Title | Faculty |
---|---|---|
5:10 PM - 5:30 PM | Q&A Panel with Authors | Faculty |
Speaker | Disclosure |
---|
Start Time | Pub. | Title | Presenter |
---|---|---|---|
3:30 PM | 002 | Sensitive Assessment of Duchenne Muscular Dystrophy Progression with a Dedicated Electrical Impedance Myography Device |
Disclosure: Dr. Rutkove has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Myolex, Biogen, Axcella Health, Merck. Dr. Rutkove has received personal compensation in an editorial capacity for Annals of Neurology. Dr. Rutkove has received compensation for serving on the Board of Directors of Myolex, Inc. Dr. Rutkove holds stock and/or stock options in Myolex, Inc.
|
3:30 PM | 003 | Genetic Prevalence of Myotonic Dystrophy Type 1 |
Disclosure: Dr. Johnson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acceleron, Strongbridge, Vertex, Fulcrum, and AveXis. Dr. Johnson has received personal compensation in an editorial capacity for Continuum. Dr. Johnson has received royalty, license fees, or contractual rights payments from University of Rochester. Dr. Johnson has received research support from Acceleron, CSL Behring, Fulcrum, Vertex, and AveXis.
|
3:30 PM | 004 | Breaking the sound barrier of randomized, controlled trials in congenital myopathies: results of the N-acetylcysteine trial in RYR1-related disorders |
Disclosure: Dr. Todd has nothing to disclose.
|
3:30 PM | 005 | An Instrumented Timed Up and Go is Sensitive to Progression in Facioscapulohumeral Dystrophy |
Disclosure: Dr. Statland has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acceleron Pharma, Inc., Expansion Therapeutics, , Fulcrum Therapeutics, Genea Biocells, and Strongbridge Biopharma. Dr. Statland has received research support from FSH Society, Muscular Dystrophy Association, and the National Institutes of Health.
|
3:30 PM | 006 | FTX-1821 for Treatment of FSHD at its Root Cause: Results of a Clinical Trial in a Dish |
Disclosure: Dr. Mellion has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Fulcrum Therapeutics, Vertex Pharmaceuticals. Dr. Mellion holds stock and/or stock options in Vertex Pharmaceuticals which sponsored research in which Dr. Mellion was involved as an investigator. Dr. Mellion holds stock and/or stock options in Vertex Pharmaceuticals. Dr. Mellion has received research support from Fulcrum Therapeutics, Vertex Pharmaceuticals.
|
3:30 PM | 007 | Comparison of Symptom Profile in Patients with SCN4A and CLCN1 Nondystrophic Myotonias |
Disclosure: Dr. Meyer has nothing to disclose.
|
3:30 PM | 008 | Open-Label Phase 2 Clinical Trial of ManNAc for GNE Myopathy |
Disclosure: Dr. Carillo-Carrasco has received research support from Leadiant Biosciences.
|
3:30 PM | 009 | Progressive Degenerative Myofibrillar Myopathy in Knock-In Mice Expressing LDB3 p.A165V Protein: A Mouse Model for Markesbery-Griggs Distal Myopathy |
Disclosure: Dr. Blech-Hermoni has nothing to disclose.
|
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
9:30 AM-11:30 AM |
---|
C12 -
Clinical Approach to Muscle Disease I: Role of Antibodies, Muscle Imaging, and Genetic Testing
Tahseen Mozaffar MD, FAAN |
1:30 PM-3:30 PM |
C25 -
Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology
Tahseen Mozaffar MD, FAAN |
7:00 AM-9:00 AM |
---|
C46 -
Actualización en dolor de cabeza y trastornos neuromusculares (Update: Headache and Neuromuscular Disorder)
Jose Merino MD, MPhil, FAAN, Dario Beltran MD, FAAN |
C36 -
Mastering EMG Waveform Recognition Skills in Just Two Hours!
Devon Rubin MD, FAAN |
1:00 PM-3:00 PM |
C49 -
Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease
Ralph Jozefowicz MD, FAAN, Adam Quick MD |
C47 -
Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies
Amanda Peltier MD, MS |
S5 -
Therapeutics in ALS and SMA
|
3:30 PM-5:30 PM |
C65 -
Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia
Amanda Peltier MD, MS |
11:30 AM-6:30 PM |
---|
P2 -
Poster Session 2
|
1:00 PM-3:00 PM |
C101 -
Clinical EMG I: Principles and Practice of NCS and Needle EMG
Ruple Laughlin MD, FAAN |
N2 -
Neuroscience in the Clinic: Interpretations of Genetic Results
Massimo Pandolfo MD, FAAN, Karen Marder MD, MPH, FAAN |
3:30 PM-4:45 PM |
S18 -
Autonomic Disorders
|
3:30 PM-5:30 PM |
C120 -
Clinical EMG II: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography
Ruple Laughlin MD, FAAN |
7:00 AM-9:00 AM |
---|
C121 -
Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches
Mark Bromberg MD, PhD, FAAN |
9:15 AM-11:30 AM |
Clinical Trials Plenary Session
Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN |
11:30 AM-6:30 PM |
P3 -
Poster Session 3
|
1:00 PM-3:00 PM |
C131 -
Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System
Christopher Gibbons MD, FAAN |
S25 -
Child Neurology: Spinal Muscular Atrophy: Treatments and Outcomes
|
1:00 PM-5:30 PM |
C148 -
Skills Workshop: EMG: Basic
(Registration Required)
Holli Horak MD, FAAN |
3:30 PM-5:30 PM |
C150 -
Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System
Christopher Gibbons MD, FAAN |
Presentation of the Sheila Essey Award: An Award for ALS Research
|
7:00 AM-9:00 AM |
---|
C171 -
Child Neurology: Neuromuscular/Autoimmune Neurology
Anne Connolly MD, FAAN |
11:30 AM-6:30 PM |
P4 -
Poster Session 4
|
1:00 PM-3:00 PM |
C175 -
Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia
Laura Tormoehlen MD, FAAN |
N4 -
Neuroscience in the Clinic: Immunotherapies in Neurological Disease
Holly Hinson MD, MCR, FAAN, John Corboy MD, FAAN |
1:00 PM-5:30 PM |
C191 -
Skills Workshop: Neuromuscular Ultrasound
(Registration Required)
Craig Zaidman MD |
3:30 PM-5:30 PM |
C192 -
Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission
Laura Tormoehlen MD, FAAN |
C195 -
Therapy in Neurology II: Neurocritical Care and Neuromuscular Disease
Madhu Soni MD, FAAN |
S42 -
Neuromuscular Disorders
|
7:00 AM-9:00 AM |
---|
C205 -
Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies
David Herrmann MD, FAAN |
C214 -
Child Neurology: A Case-based Approach
Elaine Wirrell MD, FAAN |
11:30 AM-6:30 PM |
P5 -
Poster Session 5
|
1:00 PM-3:00 PM |
C215 -
Peripheral Neuropathy II: Update on Diabetic, Immune Axonal, and Hematologic-related Neuropathies
Michelle Mauermann MD, FAAN |
3:30 PM-5:30 PM |
C229 -
Peripheral Neuropathy III: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives
Mario Saporta MD, PhD, FAAN |
S54 -
Motor Neuron Disease
|
7:00 PM-10:00 PM |
C237 -
Case Studies: Diagnosis and Management of Unusual Cases in Neuromuscular Disease
Robert Pascuzzi MD, FAAN |
7:00 AM-9:00 AM |
---|
C243 -
Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis
Michael Weiss MD, FAAN |
9:15 AM-11:30 AM |
Neurology Year in Review Plenary Session
Martinson Arnan MD |
1:00 PM-3:00 PM |
S58 -
Therapeutics in Neuromuscular Disorders
|
2:00 PM-2:45 PM |
Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 1
Nicholas Johnson MD, FAAN |
Consensus-Based Care Recommendations for Adults with haha
|